144 related articles for article (PubMed ID: 3261998)
1. [The nature of immunodeficiency induced by injections of lectins and cyclophosphamide].
Kondrat'eva TK; Mikheeva NV; Fontalin LN
Biull Eksp Biol Med; 1988 Aug; 106(8):195-8. PubMed ID: 3261998
[TBL] [Abstract][Full Text] [Related]
2. [Mechanisms of polyclonal tolerance induced by lipopolysaccharide and cyclophosphamide].
Kondrat'eva TK; Fontalin LN; Mikheeva NV; Golan' V
Biull Eksp Biol Med; 1987 Oct; 104(10):483-5. PubMed ID: 3118987
[TBL] [Abstract][Full Text] [Related]
3. Combination chemotherapy and IL-15 administration induce permanent tumor regression in a mouse lung tumor model: NK and T cell-mediated effects antagonized by B cells.
Chapoval AI; Fuller JA; Kremlev SG; Kamdar SJ; Evans R
J Immunol; 1998 Dec; 161(12):6977-84. PubMed ID: 9862733
[TBL] [Abstract][Full Text] [Related]
4. Splenic modifications induced by cyclophosphamide in C3H/He, nude, and "B" mice.
Kolb JP; Poupon MF; Lespinats GM; Sabolovic D; Loisillier F
J Immunol; 1977 May; 118(5):1595-9. PubMed ID: 300749
[TBL] [Abstract][Full Text] [Related]
5. The capacity of microsomally-activated cyclophosphamide to induce immunosuppression in vitro.
Shand FL
Immunology; 1978 Dec; 35(6):1017-25. PubMed ID: 33118
[TBL] [Abstract][Full Text] [Related]
6. Cyclophosphamide-induced appearance of immunopotentiating T-cells in the spleens of mice bearing a large MOPC-315 tumor.
Ye QW; Mokyr MB
Cancer Res; 1984 Sep; 44(9):3873-9. PubMed ID: 6611201
[TBL] [Abstract][Full Text] [Related]
7. Studies on induction and control of cell-mediated autoimmunity. II. Prevention of induction and activity of autoreactive T cells by suppressor cells and by a suppressive serum factor.
L'age-Stehr J; Diamantstein T
Eur J Immunol; 1978 Sep; 8(9):624-8. PubMed ID: 309399
[TBL] [Abstract][Full Text] [Related]
8. Regulation of delayed-type hypersensitivity reactions by cyclophosphamide-sensitive T cells.
Schwartz A; Askenase PW; Gershon RK
J Immunol; 1978 Oct; 121(4):1573-7. PubMed ID: 308970
[TBL] [Abstract][Full Text] [Related]
9. Drug-induced immunological unresponsiveness: selective inhibition of T-cell 'helper function' by cyclophosphamide in mice pretreated with phytohaemagglutinin.
Schwarze G
Clin Exp Immunol; 1977 Jan; 27(1):178-82. PubMed ID: 321157
[TBL] [Abstract][Full Text] [Related]
10. Some characteristics of the cyclophosphamide-induced immunopotentiating cells in the spleen of mice bearing a large MOPC-315 tumor.
Mokyr MB; Ye QW
Cancer Res; 1985 Oct; 45(10):4932-9. PubMed ID: 4027979
[TBL] [Abstract][Full Text] [Related]
11. A technique for inducing B-cell ablation in chickens by in ovo injection of cyclophosphamide.
Reynolds DL; Maraqa AD
Avian Dis; 1999; 43(3):367-75. PubMed ID: 10494404
[TBL] [Abstract][Full Text] [Related]
12. [Participation of lymphoid organ T- and B-lymphocytes in transplantation immunity in immune deficiency modeled with anti-thymus serum and cyclophosphamide].
Antonenko VT; Chornen'ka VD
Fiziol Zh; 1977; 23(6):733-40. PubMed ID: 338369
[No Abstract] [Full Text] [Related]
13. Participation of cyclophosphamide-sensitive T cells in graft-vs-host reactions.
Schwartz A; Orbach-Arbouys S; Gershon RK
J Immunol; 1976 Sep; 117(3):871-5. PubMed ID: 8571
[TBL] [Abstract][Full Text] [Related]
14. Ganoderma lucidum polysaccharides enhance the function of immunological effector cells in immunosuppressed mice.
Zhu XL; Chen AF; Lin ZB
J Ethnopharmacol; 2007 May; 111(2):219-26. PubMed ID: 17182202
[TBL] [Abstract][Full Text] [Related]
15. Acceleration of age-associated immune decline and mortality by early repeated administration of bestatin to C57BL/6 mice.
Bruley-Rosset M; Payelle B; Rappaport H
J Biol Response Mod; 1986 Apr; 5(2):176-90. PubMed ID: 3488372
[TBL] [Abstract][Full Text] [Related]
16. [Relationship between T- and B-lymphocyte cooperation and their syngeneity].
Fontalin LN; Novikova TK; PevnitskiÄ LA; Kondrat'eva IA
Biull Eksp Biol Med; 1976 Mar; 81(3):325-7. PubMed ID: 1085176
[TBL] [Abstract][Full Text] [Related]
17. Studies on induction and control of cell-mediated autoimmunity. I. Induction of "autoreactive" T lymphocytes in mice by cyclophosphamide.
L'age-Stehr J; Diamantstein T
Eur J Immunol; 1978 Sep; 8(9):620-4. PubMed ID: 309398
[TBL] [Abstract][Full Text] [Related]
18. The cellular control of delayed hypersensitivity to Staphylococcus aureus in mice.
Easmon CS; Glynn AA
Immunology; 1979 Sep; 38(1):103-8. PubMed ID: 159861
[TBL] [Abstract][Full Text] [Related]
19. Polyclonal B cell anergy induced by bacterial lipopolysaccharide and cyclophosphamide.
Fontalin LN; Kondratieva TK; Kondratieva IA; Smirnova IN; Mikheeva NV
Folia Biol (Praha); 1988; 34(2):72-83. PubMed ID: 3294050
[TBL] [Abstract][Full Text] [Related]
20. The origin of cytotoxic T lymphocyte precursors (CTL-P): MHC-restricted and alloreactive CTL-P in the spleen during regeneration after a sublethal dose of cyclophosphamide (Cy).
Sihvola M; Hurme M
J Immunol; 1983 Mar; 130(3):1077-83. PubMed ID: 6600471
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]